Verastem financial statements
베라스템NASDAQ:VSTM · Nasdaq · Healthcare$7.70-2.53%
2026-10-02 closeVerastem's published financial data is dated 2026-10-04. 2024 revenue was $10M. 2024 operating profit was −$115M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy